<DOC>
	<DOCNO>NCT02250274</DOCNO>
	<brief_summary>The purpose study assess serologic cell-mediated immune response license live attenuated influenza vaccine ( LAIV ) inactivate influenza vaccine ( IIV ) child 5-17 year old . The effect prior infection prior season vaccination examine . Children follow influenza season identify laboratory-confirmed influenza ( i.e . vaccine failure ) .</brief_summary>
	<brief_title>Randomized Study Immune Response Licensed Influenza Vaccines Children Adolescents</brief_title>
	<detailed_description>All child baseline blood sample draw vaccinate licensed approve influenza vaccine . Following recommendation Advisory Committee Immunization Practices , child 5-8 year old preferentially receive live attenuate influenza vaccine ( LAIV ) . Children age 9-17 randomized receive either LAIV inactivate influenza vaccine ( IIV ) . Children medical contraindication license influenza vaccine exclude study . The child blood drawn 2 4 time total course two month order test immune response vaccine . Between approximately December April , study participant contact weekly monitor new respiratory illness cough , present , nasal throat swab collect test influenza .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 517 year duration study period ( Sept 1 , 2014Apr 1 , 2015 ) Enrolled either immune response study vaccine effectiveness study conduct site 201314 influenza season If enrol vaccine effectiveness study previous season must either vaccinate infected influenza unvaccinated uninfected influenza Children contraindication either quadrivalent live attenuate influenza vaccine trivalent inactivate influenza vaccine exclude . Anyone unwilling unable complete require study activity include informed consent Subjects already receive influenza vaccine 201415 season</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Immune response influenza vaccine</keyword>
	<keyword>PCR confirm Influenza A virus</keyword>
	<keyword>PCR confirm Influenza B virus</keyword>
</DOC>